최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
DataON 바로가기다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
Edison 바로가기다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
Kafe 바로가기국가/구분 | United States(US) Patent 등록 |
---|---|
국제특허분류(IPC7판) |
|
출원번호 | US-0064094 (2011-03-04) |
등록번호 | US-9656261 (2017-05-23) |
발명자 / 주소 |
|
출원인 / 주소 |
|
대리인 / 주소 |
|
인용정보 | 피인용 횟수 : 0 인용 특허 : 366 |
Aspects of the disclosure provide a microfluidic chip to facilitate DNA analysis. The microfluidic chip includes a first domain configured for polymerase chain reaction (PCR) amplification of DNA fragments, a dilution domain coupled to the first domain to dilute a PCR mixture received from the first
Aspects of the disclosure provide a microfluidic chip to facilitate DNA analysis. The microfluidic chip includes a first domain configured for polymerase chain reaction (PCR) amplification of DNA fragments, a dilution domain coupled to the first domain to dilute a PCR mixture received from the first domain, and a second domain that is coupled to the dilution domain so as to receive the amplified DNA fragments. The second domain includes a separation channel that is configured to perform electrophoretic separation of the amplified DNA fragments. In addition, the disclosure provides a DNA analyzer to act on the microfluidic chip to perform an integrated single chip DNA analysis.
1. A microfluidic chip, comprising: an inlet configured to receive a template DNA extracted from a sample acceptor that is external of the microfluidic chip and is fluidically coupled to the microfluidic chip on a cartridge;a first domain configured for polymerase chain reaction (PCR) amplification
1. A microfluidic chip, comprising: an inlet configured to receive a template DNA extracted from a sample acceptor that is external of the microfluidic chip and is fluidically coupled to the microfluidic chip on a cartridge;a first domain configured for polymerase chain reaction (PCR) amplification of DNA fragments, the first domain including a thermal-coupler reservoir coupled with a PCR reservoir for PCR amplification, thermal cycles in the PCR reservoir being induced based on temperature measured from the thermal-coupler reservoir;a dilution domain having a reservoir that is fluidically coupled to the first domain and is configured to dilute a PCR mixture received from the first domain with a dilutant in the reservoir; anda second domain that is fluidically coupled to the dilution domain so as to receive the amplified DNA fragments, the second domain including a separation channel that is configured to perform electrophoretic separation of the amplified DNA fragments. 2. The microfluidic chip of claim 1, wherein: the PCR reservoir is configured to receive a template DNA and reagents, and amplify the DNA fragments based on the template DNA and the reagents. 3. The microfluidic chip of claim 2, further comprising: a plurality of inlets configured to input the template DNA and the reagents into the microfluidic chip. 4. The microfluidic chip of claim 1, wherein the second domain comprises: an injection channel configured to inject the amplified DNA fragments into the separation channel by electro-kinetic injection. 5. The microfluidic chip of claim 1, further comprising: a plurality of electrode reservoirs for applying an electric field over the separation channel. 6. The microfluidic chip of claim 1, wherein in the dilution domain, the PCR mixture and the dilutant are mixed according to a ratio from 1:5 to 1:20. 7. A cartridge, comprising: a sample acceptor external to and fluidically coupled to a microfluidic chip on the cartridge,the sample acceptor configured to extract a template DNA and the microfluidic chip having a first domain and a second domain coupled to the first domain, wherein the first domain is configured to perform polymerase chain reaction (PCR) amplification of DNA fragments based on the template DNA, and the second domain has a separation channel that is configured to perform electrophoretic separation of the amplified DNA fragments, the first domain includes a thermal-coupler reservoir coupled with a PCR reservoir for PCR amplification, thermal cycles in the PCR reservoir are induced based on temperature measured from the thermal-coupler reservoir. 8. The cartridge of claim 7, further comprising: a reagent carrier configured to carry reagents for the PCR amplification, and solutions for the electrophoretic separation. 9. The cartridge of claim 7, wherein the sample acceptor is configured to extract the template DNA by at least one of a silica solid phase extraction, and a liquid phase enzymatic DNA isolation. 10. The cartridge of claim 7, wherein the sample acceptor comprises: a well having a liquid phase mixture to extract the template DNA. 11. The cartridge of claim 10, wherein the liquid phase mixture is sealed in the well before the extraction. 12. The cartridge of claim 8, wherein: the PCR reservoir is configured to receive the extracted template DNA and the reagents, and amplify the DNA fragments based on the template DNA and the reagents. 13. The cartridge of claim 8, wherein the microfluidic chip further comprises: a plurality of inlets configured to input the template DNA and the reagents kits into the microfluidic chip. 14. The cartridge of claim 7, wherein the second domain of the microfluidic chip comprises: an injection channel configured to inject the amplified DNA fragments into the separation channel by electro-kinetic injection. 15. The cartridge of claim 7, wherein the microfluidic chip further comprises: a plurality of electrode reservoirs for applying an electric field over the separation channel. 16. The cartridge of claim 7, wherein the microfluidic chip further comprises: a waste outlet to drain liquid out of the microfluidic chip. 17. The cartridge of claim 7, wherein the microfluidic chip further comprises: a dilution domain coupled to the first domain and the second domain, the dilution domain diluting a PCR mixture received from the first domain with a dilutant, and providing the diluted PCR mixture to the second domain. 18. The cartridge of claim 17, wherein in the dilution domain, the PCR mixture and the dilutant are mixed according to a ratio from 1:5 to 1:20. 19. The cartridge of claim 10, wherein the liquid phase mixture is capable of performing enzymatic digestion of proteins and other cellular interferences, with the exception of DNA.
Copyright KISTI. All Rights Reserved.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.